“Bimekizumab Efficacy and Safety through Two Years in Patients With Moderate Psoriasis: Analysis of Pooled Data from Five Phase 3 3b Clinical Trials”. SKIN The Journal of Cutaneous Medicine 6, no. 6 (November 16, 2022): s67. Accessed April 16, 2025. https://skin.dermsquared.com/skin/article/view/1822.